Rivus Scores $132M to Advance Weight problems Drug, Cardio-Metabolic Pipeline

Rivus CEO Allen Cunningham/courtesy of Rivus Prescribed drugs Rivus Prescribed drugs raised $132 million in a Collection B financing spherical, the corporate revealed Thursday. Proceeds will likely be used to advance the event of HU6, a brand new class of drug designed to deal with cardio-metabolic illness by addressing weight problems. Rivus CEO Allen Cunningham informed BioSpace the […]